Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRUISE 2: Triferic in Hemodialysis
NCT01322347Phase 3Completed
- Sponsor
- Rockwell Medical
- Start
- Apr 2011
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of ferric pyrophosphate in anemia of chronic kidney disease (CKD-A), sponsored by Rockwell Medical. Started Apr 2011; status: completed.
02
Drugs
ferric pyrophosphate
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01322347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01322347.